Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

July
10
2018

Sensus Healthcare and CellMark Medical Partner to Accelerate International Expansion and Growth for Innovative Oncology and Aesthetic Solutions

BOCA RATON, Fla., July 10, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), and CellMark Medical,…

July
06
2018

People Magazine – 42-Year-Old Woman Has Survived 86 Skin Cancer Surgeries

Lisa Pace has had 86 skin cancer surgeries and she’s only 42 years old. She was in her 20s when she discovered she had skin cancer after years of using tanning beds. In her interview with People Magazine, she discusses…

July
01
2018

 Skin Cancer and SRT – Jeff Goldstein Interview

All transplant patients have a greater chance of developing skin cancer compared to the general population. In fact, research shows that transplant recipients have up to a 100 times higher risk for developing skin cancer…

June
26
2018

Utilizing the SRT Keloid Treatment To Help Change Lives

The SRT Keloid Treatment helps to change lives. To show you just how effective SRT can be for keloids, we wanted to share the story of a patient who was successfully treated with the SRT-100….

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy